Fennec Pharmaceuticals Inc expected to post a loss of 14  cents a share - Earnings Preview

Fennec Pharmaceuticals

09/05/2022 19:33

* Fennec Pharmaceuticals Inc  FENC.OQ   FENC.O  is expected
to show no change in quarterly revenue when it reports 
results on May 11 (estimated). 
    * ​Refinitiv's mean analyst estimate for Fennec
Pharmaceuticals
Inc is for a loss of 14 cents per share. For the same quarter
last year, the company reported a loss of 18 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Fennec
Pharmaceuticals Inc is $10​, above​ its last closing price
of $5.76. ​​​

This summary was machine generated May 9 at 18:32 GMT.  All
figures in US dollars  unless otherwise stated